AS ONE Corporation (7476)

Name: AS ONE Corporation (7476) — storico dei bilanci
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-10-02

AS ONE Corporation engages in the sale of research instruments and equipment, nursing and care products, and other scientific instruments in Japan and internationally.

Dati chiave

Capitalizzazione di mercato: JPY 175 billion
Ricavi (esercizio chiuso a 2026-03-31): JPY 110.7B
Utile netto: JPY 9.2B
Margine lordo: 30.2%
Margine netto: 8.3%

Vedi grafici interattivi e bilanci completi → Modello di valutazione (DCF) →

Conto economico annuale

Conto economico	2026-03-31	2025-03-31	2024-03-31	2023-03-31	2022-03-31
Entrate totali	JPY 110.7B	JPY 103.8B	JPY 95.5B	JPY 91.4B	—
Utile lordo	JPY 33.5B	JPY 31.3B	JPY 29.2B	JPY 28.5B	—
Risultato Operativo (EBIT)	JPY 12.8B	JPY 11.6B	JPY 10.4B	JPY 11.4B	—
Reddito netto	JPY 9.2B	JPY 8.2B	JPY 7.5B	JPY 8.1B	—

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di 7476. /companies/us/7476

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.